BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2147456)

  • 1. [HBsAG-positive mothers and neonatal immunization: experience at the USL No. 1 in Trapani].
    Bonanno Conti MI; Critti AF; La Rocca S; Rappa AR
    Minerva Pediatr; 1990 Jun; 42(6):233-5. PubMed ID: 2147456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B vaccination in children: the Taiwan experience.
    Ni YH; Chen DS
    Pathol Biol (Paris); 2010 Aug; 58(4):296-300. PubMed ID: 20116181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A combination of hepatitis B vaccine and immunoglobulin does not protect all infants born to hepatitis B e antigen positive mothers.
    Farmer K; Gunn T; Woodfield DG
    N Z Med J; 1987 Jul; 100(827):412-4. PubMed ID: 2967932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of hepatitis B infection in infants born to hepatitis B carrier mothers: low dosage vaccination.
    Theppisai U; Thanuntaseth C; Chiewsilp P; Siripoonya P
    Int J Gynaecol Obstet; 1990 Aug; 32(4):353-7. PubMed ID: 1977630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined passive and active immunization for interruption of perinatal transmission of hepatitis B virus in Taiwan.
    Lo KJ; Tsai YT; Lee SD; Yeh CL; Wang JY; Chiang BN; Wu TC; Yeh PS; Goudeau A; Coursaget P
    Hepatogastroenterology; 1985 Apr; 32(2):65-8. PubMed ID: 3159639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hepatitis B screening in late pregnancy and results of immunization in newborn infants].
    Sidiropoulos D; Wegmann G; Bütler R; von Muralt G
    Schweiz Med Wochenschr; 1988 Mar; 118(9):309-12. PubMed ID: 2965828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination against hepatitis B virus infection in neonates.
    Pongpipat D; Suvatte V; Assateerawatts A
    Helv Paediatr Acta; 1984 Aug; 39(3):231-6. PubMed ID: 6242403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of hepatitis B virus infection in children born to HBsAg positive/HBeAg positive mothers. Preliminary results of active and passive-active immunization.
    Goudeau A; Lo KJ; Coursaget P; Tong MJ; Yeh CL; Tsai YT; Lee JK; Wu TC; Yeh SH; Lee SD
    Dev Biol Stand; 1983; 54():399-404. PubMed ID: 6228473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of perinatal hepatitis B transmission in Haimen City, China: Results of a community public health initiative.
    Evans AA; Cohen C; Huang P; Qian L; London WT; Block JM; Chen G
    Vaccine; 2015 Jun; 33(26):3010-5. PubMed ID: 25698491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative evaluation of active and passive-active immunization of newborn infants born to mothers with HBV infection].
    Gładysz A; Inglot M; Molin I; Zalewska M; Maszkiewicz W; Patkowska B
    Przegl Epidemiol; 1991; 45(4):311-4. PubMed ID: 1841408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal-neonatal transmission of hepatitis B virus. Epidemiology and prevention.
    Zanetti AR
    Ann Ist Super Sanita; 1987; 24(2):277-84. PubMed ID: 2969205
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatitis B immunization in high risk neonates born from HBsAg and HBeAg positive mothers: comparison of standard and low dose regimens.
    Pongpipat D; Suvatte V; Assateerawatts A
    Asian Pac J Allergy Immunol; 1988 Dec; 6(2):107-10. PubMed ID: 2975491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Current views on the subject of vertical transmission and prevention of hepatitis B].
    Turrisi A; Buccellato A; Gucciardo D; Mignano-Marù R; Ziino O; Borsellino F; Lantieri P; Lazzara A
    Minerva Pediatr; 1989 Oct; 41(10):505-14. PubMed ID: 2693928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity and protective efficacy of low dose recombinant DNA hepatitis B vaccine in normal and high-risk neonates.
    Assateerawatt A; Tanphaichitr VS; Suvatte V; In-ngarm L
    Asian Pac J Allergy Immunol; 1991 Dec; 9(2):89-93. PubMed ID: 1839654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Success of a program of routine prenatal screening for hepatitis B surface antigen: the first 2 years.
    Okun NB; Larke RP; Waters JR; Joffres MR
    CMAJ; 1990 Dec; 143(12):1317-21. PubMed ID: 2147576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two-year study of passive-active immunization for prevention of hepatitis B infection in newborns.
    Theppisai U; Thanuntaseh C; Chiewsilp P; Siripoonya P
    J Med Assoc Thai; 1988 Aug; 71(8):413-6. PubMed ID: 2978040
    [No Abstract]   [Full Text] [Related]  

  • 17. Virologic factors associated with failure to passive-active immunoprophylaxis in infants born to HBsAg-positive mothers.
    Zou H; Chen Y; Duan Z; Zhang H; Pan C
    J Viral Hepat; 2012 Feb; 19(2):e18-25. PubMed ID: 22239517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anti-hepatitis B vaccination in Campania. Final observations of a 3-year vaccination campaign, with special reference to infants born to HBsAg-positive mothers].
    Manzillo G; Maio G; Izzo CM; Fiorentino F; De Sena R; Simioli F; Cozzolino C; Pignalosa G; Sbreglia C; Manzillo E
    Minerva Med; 1988 Jan; 79(1):15-28. PubMed ID: 2963240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new program for provision of hepatitis B vaccine to neonates of HBsAg+ mothers.
    Colo Med; 1989 Apr; 86(8):125. PubMed ID: 2523271
    [No Abstract]   [Full Text] [Related]  

  • 20. [Persistent HBsAg antigenemia in newborn infants following intrauterine HBV infection. Cause for the failure of the prevention of perinatal HBV transmission].
    Pongpipat D; Suvatte V; Assateerawatts A
    Monatsschr Kinderheilkd; 1986 Jul; 134(7):473-4. PubMed ID: 2943988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.